Followers | 33 |
Posts | 4692 |
Boards Moderated | 0 |
Alias Born | 06/02/2010 |
Tuesday, September 15, 2020 2:12:30 PM
Not the prettiest of pictures when you take into account the liabilities still hanging around evio’s neck in Oregon. If they can find a way out of that then they might be in position to start over with something between 51% and 90% of the Cali lab.
Then maybe one of two scenarios:
1. Sell short term the 90% lab @ maybe $2Million (probably a rich guess). With approx 100 million outstanding shares = share price cash out value of $.02*
Or
Long term hold that might or might not work out and result in higher share price value. Do you feel lucky?
These are TAR’s rough estimates which should not be considered with any greater weight than y’all put on any of his past forecasts. To that, it should be noted that his misses were always in over-valuing evio.
* selling a 51% interest would make the shares worth only $.01
GLTA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM